Development and Validation of the Real-World Progression in Diabetes (RAPIDS) Model.

Anirban BasuMin-Woong SohnBrian BartleKwun Chuen Gary ChanJennifer M CooperElbert Huang

Published in: Medical decision making : an international journal of the Society for Medical Decision Making (2019)

Future value of increasing medication adherence among VA patients with diabetes may lie among those who never initiate treatment or are late in initiating treatment. The first-of-its-kind real-world data-based model has the potential to carry out many complex comparative-effectiveness research (CER) studies of dynamic glucose-lowering drug regimens.

Keyphrases

type diabetes
cardiovascular disease
emergency department
metabolic syndrome
machine learning
electronic health record
big data
combination therapy
risk assessment
adipose tissue
glycemic control
current status
artificial intelligence
adverse drug
weight loss
smoking cessation